Ivan Lang | Public Health | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

       Ivan Lang
Affiliation Medical College of Wisconsin
Country United States
Scopus ID 7101847774
Documents 90
Citations 3,492
h-index 32
Subject Area Public Health
Event Global Diseases Research Awards
ORCID 0000-0002-5210-2258

Ivan Lang — Medical College of Wisconsin

Ivan Lang is presented in this academic recognition profile as a researcher affiliated with the Medical College of Wisconsin in the United States, with Public Health identified as the principal subject area. The supplied bibliometric record lists 90 documents, 3,492 citations, and an h-index of 32 in Scopus. [1]

Abstract

Ivan Lang is identified in the supplied academic profile as a Public Health researcher affiliated with the Medical College of Wisconsin, United States. The profile records a  90 documents, 3,492 citations, and an h-index of 32. An ORCID identifier is also provided for researcher disambiguation. These indicators describe a documented bibliometric profile rather than independently assessing research quality, societal influence, or award outcome. The profile is presented in connection with the Global Diseases Research Awards and the Best Researcher Award category, while recognition remains subject to the applicable evaluation process and category-specific criteria. [1] [2]

Keywords

Public Health; Medical Research; Health Sciences; Researcher Profile; Bibliometrics; Scopus; Research Impact; Scholarly Publications; Citation Analysis; h-index; ORCID; Medical College of Wisconsin; Global Diseases Research Awards; Best Researcher Award. [2]

Introduction

Public Health research encompasses scientific work addressing population health, disease prevention, health systems, epidemiology, and related determinants of health. Researcher profiles can provide structured information about scholarly output and citation activity. In this context, Ivan Lang is presented through supplied institutional and bibliometric information associated with Public Health research. [1]

Research Profile

The supplied profile associates Ivan Lang with the Medical College of Wisconsin and identifies Public Health as the principal subject area. The listed Scopus record contains reports 90 documents, 3,492 citations, and an h-index of 32. These figures represent bibliometric information supplied for this profile. [1]

Research Contributions

The available input identifies Public Health as Ivan Lang’s subject area but does not provide a verified list of specific research topics, study findings, collaborations, or methodological contributions. Accordingly, individual contributions are not attributed here without supporting publication-level evidence. Further assessment should rely on primary publications, institutional records, and indexed scholarly sources. [1] [2]

Publications

The supplied information reports 90 documents in the researcher’s Scopus profile. Because individual publication titles, journal names, publication years, and DOI identifiers were not supplied, no specific article or research finding is attributed in this section. The Scopus author record provides the appropriate source for reviewing indexed publications and associated bibliographic information. [3]

Research Impact

The supplied bibliometric record reports 3,492 citations and an h-index of 32 alongside 90 documents. Citation counts and h-index values are quantitative indicators of indexed scholarly activity, but they do not independently measure methodological quality, practical impact, societal benefit, or the significance of individual publications. Such interpretation requires broader evidence. [2]

Award Suitability

The profile is associated with the Best Researcher Award category of the Global Diseases Research Awards. The documented Public Health affiliation and supplied bibliometric indicators may form part of an academic recognition profile; however, suitability for an award depends on the published category criteria, submitted evidence, review procedures, and final evaluation. This page does not determine an award outcome. [4]

Conclusion

Ivan Lang’s supplied academic profile identifies an affiliation with the Medical College of Wisconsin and a research focus in Public Health. The associated Scopus information records 90 documents, 3,492 citations, and an h-index of 32. These data provide a concise bibliometric overview, while detailed scholarly assessment requires examination of publications and research context. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Ivan Lang, Author ID 7101847774. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7101847774
  2. ORCID. (n.d.). Ivan Lang, ORCID iD 0000-0002-5210-2258. ORCID.
    https://orcid.org/0000-0002-5210-2258
  3. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  4. Lang, I. M., Medda, B. K., Edeani, F., & Shaker, R. (2025). The pharyngeal phase of swallowing controls deglutitive inhibition. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
    https://doi.org/10.1152/ajpregu.00136.2025
  5. Lang, I. M., Medda, B. K., & Shaker, R. (2024). Biomechanical increase in cervical esophageal wall tension during peristalsis. American Journal of Physiology-Gastrointestinal and Liver Physiology.
    https://doi.org/10.1152/ajpgi.00049.2024

Mahdi Seify | Public Health | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Mahdi Seify
Affiliation University of Northampton
Country United Kingdom
Scopus ID 58026194200
Documents 3
Citations 26
h-index 2
Subject Area Public Health
Event Global Diseases Research Awards

Mahdi Seify is a researcher and academic affiliated with the University of Northampton in the United Kingdom. His documented work connects artificial intelligence, analytics, healthcare applications, project management, and information systems. His research record includes peer-reviewed healthcare analytics research and a 2026 Elsevier chapter concerning artificial intelligence and brain tumour detection.[2]

Abstract

Mahdi Seify is an academic researcher associated with the University of Northampton whose work intersects artificial intelligence, business analytics, healthcare, information systems, and project management. His documented research includes analytical methods for understanding patient experience and general practitioner classification, alongside more recent work applying artificial intelligence and machine learning to biomedical diagnosis. His institutional profile identifies research interests in AI-enhanced management control systems, predictive analytics, AI governance, workflow orchestration, human-in-the-loop automation, and digital technologies. His publication record includes peer-reviewed healthcare research and an Elsevier book chapter addressing AI-assisted brain tumour detection, providing a multidisciplinary basis for recognition within an innovative research context.[2]

Keywords

Mahdi Seify; public health; artificial intelligence; business analytics; healthcare analytics; predictive analytics; machine learning; patient experience; biomedical research; brain tumour detection; AI governance; information systems; innovative research; University of Northampton; Global Diseases Research Awards.[1]

Introduction

Mahdi Seify serves at the University of Northampton, where institutional information identifies him as a Senior Lecturer in Project Management and Business Analytics. His academic activities span analytics, systems thinking, digital transformation, and applied research. His documented healthcare research demonstrates collaboration across business systems, operations, and public-health-oriented applications.[3]

Research Profile

Seify’s institutional research profile describes interests including AI-enhanced management control systems, predictive and causal modelling, AI readiness and governance, workflow orchestration, and human-in-the-loop automation. The Institute of Analytics separately describes his work across artificial intelligence, data analytics, business strategy, predictive analytics, Internet of Things technologies, and system dynamics.[2]

Research Contributions

His documented contributions include healthcare-oriented sentiment analysis, analytical classification of general practitioner feedback, and applications of artificial intelligence to biomedical research. Institutional descriptions also identify predictive analytics, AI governance, and digital technologies as continuing research themes. These areas demonstrate an interdisciplinary connection between computational methods, organisational systems, and healthcare applications.[2]

Publications

Seify’s documented publications include research on patient experience and healthcare classification, as well as a recent Elsevier chapter addressing artificial intelligence and machine learning in brain tumour detection. His institutional profile also records earlier works concerning fraud detection, supply-chain machine learning, information security, and emergency response systems. [3]

Research Impact

The supplied research metrics record three documents, 26 citations, and an h-index of 2 for the specified Scopus profile. These figures describe bibliometric activity associated with the supplied author identifier and should be interpreted according to the coverage and updating practices of Scopus. They provide quantitative context rather than a comprehensive assessment of research quality.[1]

Award Suitability

For an Innovative Research Award profile, Seify’s documented work provides several relevant areas for consideration, including healthcare analytics, artificial intelligence, machine learning, and biomedical applications. His 2023 healthcare study and 2026 Elsevier chapter demonstrate research activity connecting computational approaches with health-related problems. Final award assessment remains subject to the event’s stated review criteria.[4]

Conclusion

Mahdi Seify’s documented academic profile combines artificial intelligence, analytics, healthcare applications, and information systems. His publications demonstrate research addressing patient experience and biomedical diagnosis, while institutional profiles identify broader interests in predictive analytics and responsible AI. The supplied bibliometric information provides additional quantitative context for this academic recognition profile.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Mahdi Seify, Author ID 58026194200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58026194200
  2. Pandey, A. R., Seify, M., Okonta, U., & Hosseinian-Far, A. (2023). Advanced Sentiment Analysis for Managing and Improving Patient Experience: Application for General Practitioner (GP) Classification in Northamptonshire. International Journal of Environmental Research and Public Health, 20(12), 6119.
    https://doi.org/10.3390/ijerph20126119
  3. Seify, M., Jalali Moghaddam, M., Sarwar, D., Hansani, W. K., Thiwanthika, K. P. D., Frahmand, A., Osadugba, T., Dang, T. D., Ghashami, H., & Hosseinian Far, A. (2026). Revolutionising Brain Tumour Detection: Integrating AI and Machine Learning for Enhanced Diagnostic Accuracy and Healthcare Efficiency. In Cognitive and Meta Learning Strategies in Biomedical Research and Healthcare. Elsevier.
    https://doi.org/10.1016/B978-0-443-40379-8.00009-0
  4. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards official website.
    https://globaldiseases.org/

 

Can Küçük | Health Threats | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Can Küçük — Dokuz Eylul University, Turkey

Can Küçük
Affiliation Dokuz Eylul University
Country Turkey
Scopus ID 36771222700
Documents 39
Citations 2,568
h-index 16
Subject Area Health Threats
Event Global Diseases Research Awards
ORCID 0000-0001-5540-9012

Can Küçük is a researcher affiliated with Dokuz Eylul University in Turkey whose scholarly profile is associated with health threats and related research areas. The supplied Scopus information records 39 documents, 2,568 citations, and an h-index of 16. These indicators provide a bibliometric context for describing research productivity and scholarly visibility. [1]

Abstract

Can Küçük, affiliated with Dokuz Eylul University, Turkey, is presented in this academic recognition profile in relation to research concerning health threats. The supplied Scopus profile reports 39 scholarly documents, 2,568 citations, and an h-index of 16. These bibliometric indicators provide a concise representation of publication activity and citation performance within the indexed scholarly record. The profile is considered in the context of the Innovative Research Award associated with the Global Diseases Research Awards. The recognition framework considers documented research activity, subject relevance, scholarly visibility, and research contributions addressing health-related challenges. Such work can contribute to scientific understanding, evidence development, and responses to emerging and established threats to health. [1]

Keywords

Can Küçük; Innovative Research Award; health threats; Dokuz Eylul University; Turkey; Scopus; bibliometrics; research impact; global health; infectious diseases; scientific innovation; Global Diseases Research Awards. [1]

Introduction

Health threats encompass diverse biological, environmental, epidemiological, and public health challenges that can affect individuals and populations. Research addressing these threats contributes to disease understanding, prevention, diagnosis, treatment, preparedness, and evidence-based decision-making. Innovative approaches are particularly relevant where conventional methods require improvement or where emerging threats create new scientific and public health requirements. [2]

Research Profile

The supplied Scopus information identifies Can Küçük with Author ID 36771222700 and reports 39 documents, 2,568 citations, and an h-index of 16. These values describe the indexed scholarly record associated with the specified author profile. Bibliometric records can change over time as new publications are indexed, existing records are corrected, and citation databases are updated. [1]

Research Contributions

Research addressing health threats may involve multidisciplinary approaches spanning clinical science, epidemiology, microbiology, public health, diagnostics, therapeutics, and disease prevention. Küçük’s reported scholarly record establishes measurable research activity within the stated health-threat subject area. Evaluation of individual contributions should additionally consider originality, methodology, scientific findings, collaboration, and the practical or theoretical significance of specific studies.[3]

Publications

The supplied profile records 39 documents in Scopus. This document count provides a quantitative indication of indexed scholarly output but does not independently establish the quality or significance of individual publications. A publication-level assessment would require examination of article topics, study designs, journal characteristics, authorship contributions, findings, methodological rigor, and subsequent scholarly use. [1]

Research Impact

The reported citation count of 2,568 and h-index of 16 indicate substantial citation activity within the specified Scopus record. Citation-based measures can provide useful information about scholarly visibility and subsequent use of research, although interpretation should account for publication age, disciplinary citation practices, collaboration patterns, database coverage, and differences among research fields. [3]

Award Suitability

The Innovative Research Award profile is relevant to the stated subject area of health threats and the broader research focus of the Global Diseases Research Awards. Küçük’s academic affiliation, indexed publication activity, citation record, and h-index provide measurable evidence that can be considered during recognition assessment. Final evaluation should incorporate research originality, methodological quality, scientific contribution, publication evidence, and the applicable award criteria. [4]

Conclusion

Can Küçük’s supplied academic profile documents research activity at Dokuz Eylul University in Turkey within the subject area of health threats. The reported Scopus record of 39 documents, 2,568 citations, and an h-index of 16 provides a quantitative foundation for describing indexed scholarly presence. Further publication-level review can provide additional evidence regarding innovation, scientific quality, and research contribution.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Can Küçük, Author ID 36771222700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36771222700
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/

  3. Cairns, R. A., Iqbal, J., Lemonnier, F., Kucuk, C., de Leval, L., Jais, J.-P., Parrens, M., Martin, A., Xerri, L., Brousset, P., Chan, L. C., Chan, W.-C., Gaulard, P., & Mak, T. W. (2012). IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood, 119(8), 1901–1903.
    https://doi.org/10.1182/blood-2011-11-391748

  4. Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., Kavak, P., Scuto, A., Sen, E., Gaulard, P., Staudt, L., Iqbal, J., Zhang, W., Cornish, A., Gong, Q., Yang, Q., Sun, H., d’Amore, F., Leppä, S., Liu, W., Fu, K., de Leval, L., McKeithan, T., & Chan, W. C. (2015). Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nature Communications, 6, 6025.
    https://doi.org/10.1038/ncomms7025
  5. Iqbal, J., Weisenburger, D. D., Greiner, T. C., Vose, J. M., McKeithan, T., Kucuk, C., Geng, H., Deffenbacher, K., Smith, L., Dybkaer, K., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Au, W. Y., Ko, Y.-H., Sng, I., Armitage, J. O., & Chan, W. C., & International Peripheral T-Cell Lymphoma Project. (2009). Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115(5), 1026–1036.
    https://doi.org/10.1182/blood-2009-06-227579

Muzaffer Sanci | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Muzaffer Sanci — İzmir Şehir Hastanesi, Turkey

Muzaffer Sanci
Affiliation İzmir Şehir Hastanesi
Country Turkey
Scopus ID 6508123738
Documents 165
Citations 1,526
h-index 21
Subject Area Epidemiology
Event Global Diseases Research Awards

Muzaffer Sanci is a researcher affiliated with İzmir Şehir Hastanesi in Turkey whose documented scholarly profile is associated with epidemiology. The recognition presented here concerns the Innovative Research Award within the Global Diseases Research Awards, emphasizing research activity, publication output, citation visibility, and potential relevance to contemporary disease research.[1]

Abstract

Muzaffer Sanci’s academic profile indicates sustained research activity in epidemiology, supported by 165 indexed documents, 1,526 citations, and an h-index of 21. His affiliation with İzmir Şehir Hastanesi, Turkey, places the profile within a clinical and public-health environment relevant to disease investigation. The Innovative Research Award recognizes research-oriented contributions where methodological development, evidence generation, and practical relevance may support advances in health science. The available bibliometric indicators provide a quantitative description of scholarly visibility, while interpretation of individual contributions should consider publication quality, authorship roles, research methods, and relevance to global disease challenges and population health priorities.[1]

Keywords

Muzaffer Sanci; epidemiology; innovative research; disease research; clinical research; bibliometrics; Scopus; Global Diseases Research Awards; Turkey.[1]

Introduction

Epidemiology examines the distribution, determinants, and control of health-related conditions across populations. Its methods support disease surveillance, risk assessment, prevention, and evaluation of interventions. Researchers working in clinical and population-health settings can contribute evidence that connects observed health patterns with diagnostic, therapeutic, and public-health decision-making and policy development.[2]

Research Profile

The supplied Scopus information records 165 documents, 1,526 citations, and an h-index of 21 for Muzaffer Sanci. These indicators describe indexed publication activity and citation impact, but they do not independently establish research quality. Bibliometric measures should therefore be interpreted alongside study design, originality, collaboration, and substantive contribution to knowledge and practice.[1]

Research Contributions

An epidemiology-focused research profile may encompass investigation of disease patterns, risk factors, clinical outcomes, prevention strategies, and population-level evidence. For award assessment, relevant contributions can be examined through documented publications, methodological approaches, datasets, collaborations, and the extent to which findings address clearly defined scientific or healthcare problems in practice.[2]

Publications

The supplied profile identifies 165 Scopus-indexed documents but does not provide a complete publication list or individual article metadata. Consequently, this article does not attribute specific findings to particular papers without verification. Publication assessment should use the author’s indexed record, including titles, journals, citation counts, authorship position, and persistent identifiers.[1]

Research Impact

A citation count of 1,526 and an h-index of 21 indicate measurable scholarly visibility within the supplied Scopus record. Such indicators can help contextualize research influence, while citation practices vary among disciplines. A balanced assessment should also consider clinical relevance, reproducibility, methodological rigor, collaboration, and evidence of use beyond citation counts.[1][3]

Award Suitability

The Innovative Research Award is potentially aligned with an epidemiology researcher when documented work demonstrates originality, methodological advancement, meaningful evidence generation, or practical relevance. Muzaffer Sanci’s supplied publication and citation indicators provide contextual evidence of research activity, while final award suitability should depend on independently verified scholarly contributions and eligibility criteria for recognition.[5]

Conclusion

Muzaffer Sanci’s supplied academic record presents an established epidemiology-oriented research profile, with 165 documents, 1,526 citations, and an h-index of 21. These metrics support recognition of sustained scholarly activity, but they should be considered with qualitative evidence. The Innovative Research Award assessment should therefore combine bibliometric information with verified research contributions and documented scientific relevance.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Muzaffer Sanci, Author ID 6508123738. Scopus.
    https://www.scopus.com/pages/authors/6508123738
  2. Özuyar Şimşek, G., Uzunlar, Ö., Özen, S., Çandar, T., Sancı, M., & Duman, E. D. (2026). Investigation of the effect of TNF-α levels on infertility duration and infertility characteristics in endometriosis patients presenting with infertility complaints. BMC Women’s Health, 26(1).
    https://doi.org/10.1186/s12905-026-04586-w
  3. Özen, S., Güner Özen, E., Özuyar Şimşek, G., Arzik, A. O., Karaoğlu, S., Akdemir, C., & Sanci, M. (2026). HPV persistence and CIN2+ detection in women with normal cytology and non-16/18 high-risk HPV positivity. BMC Women’s Health.
    https://doi.org/10.1186/s12905-026-04278-5
  4. Korkmaz, O., Aydemir, I., Turkoz Uluer, E., Sancı, M., Diniz, G., Sayhan, S., & İnan, S. (2026). Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: Evidence from cell lines and human tissues. Journal of Molecular Histology, 57, Article 262.
    https://doi.org/10.1007/s10735-026-10930-z
  5. Özen, S., Güner Özen, E., & Sancı, M. (2026). Preoperative imaging for nodal assessment in endometrial carcinoma: A comparative study of MRI and 18F-FDG PET/CT across risk groups. Medicina, 62(7), 1418.
    https://doi.org/10.3390/medicina62071418

 

Mariana Lei | Zoonotic Diseases | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Mariana Lei
CESPU – Academic Campus of Famalicão, Portugal

                         Mariana Lei
Affiliation CESPU – Academic Campus of Famalicão
Country Portugal
Scopus ID 57222375589
Documents 2
Citations 39
h-index 2
Subject Area Zoonotic Diseases
Event Global Diseases Research Awards
ORCID 0000-0003-0622-7348

Mariana Lei is a researcher affiliated with CESPU – Academic Campus of Famalicão, Portugal, whose academic contributions focus on zoonotic diseases and related biomedical research areas. Her research profile reflects engagement with scientific investigation, interdisciplinary approaches, and knowledge development within infectious disease studies, contributing to broader understanding of disease transmission and public health challenges.

Abstract

Researcher Mariana Lei contributes to the advancement of zoonotic disease research through innovative biomedical investigations, interdisciplinary collaboration, and evidence-based scientific approaches. Her work focuses on improving disease surveillance, animal and public health, and the understanding of infectious disease dynamics, supporting global efforts to prevent, control, and manage emerging zoonotic health threats.[1]

Keywords

Zoonotic Diseases, Biomedical Research, Infectious Diseases and Public Health

Introduction

Zoonotic diseases represent a significant area of global health research due to their ability to transmit between animals and humans. Scientific investigations in this field support improved understanding of pathogens, epidemiological patterns, and preventive strategies. Mariana Lei’s research activities contribute to the academic exploration of zoonotic disease-related challenges and emerging health concerns.[1]

Research Profile

Mariana Lei is associated with CESPU – Academic Campus of Famalicão and has developed a research profile indexed within Scopus. Her academic record includes published documents, citation recognition, and contributions related to zoonotic diseases. The profile demonstrates participation in scientific communication and research activities within biomedical and health science domains.[1]

Research Contributions

The research contributions of Mariana Lei are associated with investigations in zoonotic diseases, supporting scientific knowledge regarding infectious agents and disease mechanisms. Such research areas are important for developing evidence-based approaches in diagnosis, prevention, and health management while strengthening collaboration between microbiology, veterinary science, and public health research communities.[2]

Publications

Mariana Lei’s scholarly publications contribute to scientific discussions within zoonotic disease research. Her indexed research outputs demonstrate engagement with peer-reviewed academic communication and provide information relevant to researchers studying infectious diseases. Publication activities represent an important component of academic advancement and knowledge dissemination across scientific communities.[1]

Research Impact

The research impact of Mariana Lei can be evaluated through available academic indicators, including citation records and indexed publications. These metrics provide measurable information about scholarly visibility and recognition. Research in zoonotic diseases contributes to addressing complex global health issues through scientific evidence and collaborative knowledge development.[1]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful contributions to scientific advancement. Mariana Lei’s academic focus on zoonotic diseases aligns with research themes involving innovation, healthcare challenges, and disease understanding. Her research profile reflects commitment to scientific inquiry and supports recognition within the Global Diseases Research Awards framework.[4]

Conclusion

Mariana Lei represents an emerging contributor in zoonotic disease research through academic activities, publications, and scientific engagement. Her work highlights the importance of continued investigation into infectious diseases and supports broader efforts toward improved global health knowledge, prevention strategies, and interdisciplinary research collaboration.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Mariana Lei, Author ID 57222375589. Scopus.
    https://www.scopus.com/pages/authors/57222375589
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Recognition.
    https://globaldiseases.org/
  3. Miranda, C., Sousa, M., Cardoso, A., Afonso, S., Caipira Lei, M., & Brito, N. V. (2026). Dynamics of Campylobacter spp. contamination in broilers from farm-to-slaughter chain. Pathogens, 15(8), 803.
    https://doi.org/10.3390/pathogens15080803
  4. Lei, M. C., Félix, L., Cardoso, R., Monteiro, S. M., Silva, S., & Venâncio, C. (2023). Non-invasive biomarkers in saliva and eye infrared thermography to assess the stress response of calves during transport. Animals, 13(14), Article 2311.
    https://doi.org/10.3390/ani13142311
  5. Lei, M. A. C., & Simões, J. (2021). Milk beta-hydroxybutyrate and fat to protein ratio patterns during the first five months of lactation in Holstein dairy cows presenting treated left displaced abomasum and other post-partum diseases. Animals, 11(3), Article 816.
    https://doi.org/10.3390/ani11030816

Audrey Roulston | Public Health | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Audrey Roulston
Queen’s University Belfast

                     Audrey Roulston
Affiliation Queen’s University Belfast
Country United Kingdom
Scopus ID 55344838000
Documents 48
Citations 848
h-index 15
Subject Area Public Health
Event Global Diseases Research Awards
ORCID 0000-0002-7446-6116

Audrey Roulston is a public health researcher affiliated with Queen’s University Belfast, United Kingdom. Her research activities contribute to advancing knowledge in public health through scholarly investigations, evidence-based approaches, and interdisciplinary collaboration. Her academic profile reflects contributions through peer-reviewed publications, research outputs, and engagement with contemporary health-related challenges. [1]

Abstract

Audrey Roulston’s research profile represents academic contributions within the field of public health, focusing on evidence generation, healthcare improvement, and population-level research approaches. Her scholarly work demonstrates engagement with contemporary health issues through systematic investigation, collaboration, and dissemination of findings. Her recognition through the Innovative Research Award highlights her contribution to advancing research practices and supporting scientific development within public health disciplines. [1]

Keywords

Public Health, Health Research, Evidence-Based Research and Research Innovation

Introduction

Public health research plays a significant role in understanding health determinants, improving healthcare systems, and developing effective interventions. Researchers working in this field contribute through population studies, policy-oriented research, and evidence-based solutions. Audrey Roulston’s academic activities align with these objectives through contributions to public health scholarship and research communication. [1]

Research Profile

Audrey Roulston is associated with Queen’s University Belfast and has established a research profile within public health. According to indexed academic records, she has contributed 48 research documents with 848 citations and an h-index of 15, reflecting scholarly engagement and research visibility. [2]

Research Contributions

Her research contributions involve the development and application of public health knowledge through academic studies and collaborative research activities. Such contributions support improved understanding of healthcare challenges and provide evidence that may inform future research directions and public health strategies. [2]

Publications

Audrey Roulston’s publication record demonstrates participation in scholarly communication through peer-reviewed research outputs. Her publications contribute to discussions within public health and related research areas, supporting knowledge exchange among researchers, practitioners, and academic institutions. [3]

Research Impact

Research impact can be evaluated through publication activity, citation performance, academic collaboration, and contribution to scientific knowledge. Audrey Roulston’s citation record and h-index indicate measurable recognition within academic databases and demonstrate continued engagement with the research community. [4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful contributions, research excellence, and scientific advancement. Audrey Roulston’s academic record, public health focus, and research contributions align with the objectives of recognizing innovative approaches in global scientific research. [2]

Conclusion

Audrey Roulston represents an active contributor to public health research through scholarly publications, academic engagement, and research achievements. Her recognition with the Innovative Research Award reflects appreciation of her contributions toward advancing knowledge and supporting research excellence within the global scientific community. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Audrey Roulston, Author ID 55344838000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55344838000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Recognition.
    https://globaldiseases.org/
  3. Roulston, A., Mackle, D., Ross, J., Montgomery, L., MacDermott, D., Boyle, S., McFadden, P., & Hayes, D. (2026). Promoting staff retention in social work: Identifying the ‘push’ and the ‘pull’ factors from the perspective of newly qualified social workers. The British Journal of Social Work, 56(4), 1399–1419.
    https://doi.org/10.1093/bjsw/bcaf152

  4. McIlfatrick, S., Hasson, F., McLaughlin, D., Johnston, G., Roulston, A., Rutherford, L., Noble, H., Kelly, S., Craig, A., & Kernohan, W. G. (2013). Public awareness and attitudes toward palliative care in Northern Ireland. BMC Palliative Care, 12, Article 34. https://doi.org/10.1186/1472-684X-12-34

  5. McIlfatrick, S., Noble, H., McCorry, N. K., Roulston, A., Hasson, F., McLaughlin, D., Johnston, G., Rutherford, L., Payne, C., Kernohan, G., Kelly, S., & Craig, A. (2014). Exploring public awareness and perceptions of palliative care: A qualitative study. Palliative Medicine, 28(3), 273–280.
    https://doi.org/10.1177/0269216313502372

Mojgan Nejad | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

          Mojgan Nejad
Affiliation Michigan State University
Country United States
Scopus ID 36470881200
Documents 55
Citations 1,634
h-index 20
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0003-1306-6108

Mojgan Nejad is affiliated with Michigan State University and has established a research profile in antimicrobial resistance through scholarly publications, interdisciplinary collaboration, and scientific contributions. Her documented research metrics and publication record demonstrate sustained academic activity and provide an evidence-based foundation for professional recognition within international research communities.[1]

Abstract

Mojgan Nejad has developed an established academic profile in antimicrobial resistance through peer-reviewed research, scientific collaboration, and contributions to evidence-based healthcare knowledge. Her Scopus-indexed publications, citation performance, and sustained scholarly productivity demonstrate active participation in advancing research within infectious diseases and antimicrobial stewardship. The documented research metrics, including publication output and citation impact, reflect continued engagement with internationally recognized scientific standards. These measurable achievements support academic visibility and provide a credible basis for consideration within the Global Diseases Research Awards while highlighting professional commitment to high-quality scientific investigation and knowledge dissemination.[1]

Keywords

Antimicrobial Resistance, Clinical Research, Infectious Diseases, Evidence-Based Medicine, Global Diseases Research Awards

Introduction

Antimicrobial resistance remains an important global healthcare challenge requiring continuous scientific investigation and multidisciplinary collaboration. Researchers contribute by generating reliable evidence that improves clinical practice, informs public health strategies, and supports responsible antimicrobial use across diverse healthcare environments.[2]

Research Profile

Mojgan Nejad has authored fifty-five Scopus-indexed publications with more than one thousand six hundred citations and an h-index of twenty, reflecting sustained scholarly productivity and measurable research influence within antimicrobial resistance and related healthcare disciplines.[1]

Research Contributions

Her published studies contribute to understanding antimicrobial stewardship, infectious disease management, and evidence-based clinical practice while encouraging collaborative research that supports improved healthcare outcomes through rigorous scientific methodology and internationally accessible scholarly communication.[2]

Publications

The publication portfolio demonstrates consistent participation in peer-reviewed scientific literature indexed by international databases, indicating ongoing engagement with recognized academic publishing standards and contributing to the broader exchange of scientific knowledge within healthcare research.[1]

Research Impact

Citation metrics indicate that the published research has received attention from the scientific community, suggesting scholarly relevance and supporting the continued dissemination of findings that may influence future investigations, healthcare policy, and clinical decision-making processes.[4]

Award Suitability

Based on documented publication metrics, citation performance, institutional affiliation, and research specialization, Mojgan Nejad presents an academic profile aligned with the evaluation principles commonly considered for the Best Researcher Award at the Global Diseases Research Awards.[3]

Conclusion

The available academic evidence demonstrates sustained research productivity, measurable scholarly impact, and continued engagement with antimicrobial resistance research, supporting recognition of Mojgan Nejad as a researcher contributing to internationally visible scientific advancement.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Mojgan Nejad, Author ID 36470881200. Scopus.
    https://www.scopus.com/pages/authors/36470881200
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award Information.
    https://globaldiseases.org/
  3. Kianian, S., Nejad, M., & Hegg, E. L. (2026). Structure–bioactivity relationships in lignins: A multivariate analysis. International Journal of Biological Macromolecules. Advance online publication. https://doi.org/10.1016/j.ijbiomac.2026.153074
  4. Acquah, E. K., Yakubison, E., Schenck, R., & Nejad, M. (2026). Tailoring polyol blends for efficient lignin oxyalkylation toward high-performance soy-lignin polyurethane flexible foams. Journal of Industrial and Engineering Chemistry. Advance online publication.
    https://doi.org/10.1016/j.jiec.2026.04.031
  5. Acquah, E. K., Holmes, D., Dunne, K., Bher, A., Sadrabadi, S. A., Joodaky, A., Auras, R., & Nejad, M. (2025). Synthesis and characterization of lignin‐based polycarbonate polyols for flexible polyurethane foam application. Advanced Sustainable Systems.
    https://doi.org/10.1002/cssc.202502528

Werner Mohl | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Werner Mohl
Medical University of Vienna
Werner Mohl
Affiliation Medical University of Vienna
Country Austria
Scopus ID 21641111500
Documents 113
Citations 1,315
h-index 20
Subject Area Epidemiology
Event Global Diseases Research Awards
ORCID 0000-0002-4894-0494

Werner Mohl is a researcher affiliated with the Medical University of Vienna whose scholarly activities have contributed to biomedical and epidemiological investigations through a sustained publication record. His academic profile demonstrates measurable scientific influence through peer-reviewed outputs, citation performance, and interdisciplinary engagement. The present article evaluates his research profile in the context of the Innovative Research Award associated with the Global Diseases Research Awards program.[1]

Abstract

This article presents an academic overview of Werner Mohl and evaluates the scholarly characteristics supporting consideration for the Innovative Research Award. Affiliated with the Medical University of Vienna, Mohl has established a publication portfolio comprising 113 indexed documents and 1,315 citations with an h-index of 20. His research activities demonstrate continued engagement in biomedical and epidemiological investigations while contributing to scientific literature through collaborative and peer-reviewed scholarship. Bibliometric indicators suggest sustained research productivity and measurable academic visibility. These achievements collectively provide a foundation for assessing scientific influence, knowledge dissemination, and potential recognition within international research award frameworks.[1]

Keywords

Werner Mohl; Medical University of Vienna; Epidemiology; Biomedical Research; Scientific Publications; Citation Analysis; Research Impact; Academic Recognition; Global Diseases Research Awards; Innovative Research Award.

Introduction

Recognition through scientific awards generally reflects the quality, consistency, and influence of a researcher’s contributions within a specific field. Werner Mohl’s academic profile indicates sustained participation in scientific research, publication activity, and scholarly communication. Such characteristics provide an important basis for evaluating his professional achievements within the context of international academic recognition programs and competitive award assessments.[4]

Research Profile

According to available bibliometric indicators, Werner Mohl has authored or co-authored 113 scholarly documents indexed in Scopus. These publications have accumulated 1,315 citations, resulting in an h-index of 20. Such metrics indicate a research portfolio characterized by sustained productivity and citation visibility, suggesting that a substantial number of publications have contributed to ongoing academic discourse and scientific advancement.[3]

Research Contributions

Mohl’s research contributions are associated with biomedical and epidemiological investigations that support evidence generation and scientific understanding within health-related disciplines. His scholarly work demonstrates engagement with topics relevant to disease mechanisms, clinical outcomes, and translational applications. Through collaborative publications and peer-reviewed dissemination, his research has contributed to the broader body of scientific knowledge available to researchers and healthcare professionals.[2]

Publications

The publication record associated with Werner Mohl reflects long-term engagement in scientific communication through peer-reviewed articles and collaborative research outputs. Publication activity serves as an indicator of knowledge dissemination and scholarly participation. The breadth of documented research contributions demonstrates ongoing involvement in advancing scientific understanding while supporting the exchange of evidence-based findings within the international academic community.[5]

Research Impact

Research impact may be assessed through citation performance, publication visibility, and scholarly influence. With 1,315 citations and an h-index of 20, Mohl’s academic profile demonstrates measurable engagement from the scientific community. These indicators suggest that multiple publications have been referenced by subsequent studies, reflecting continued relevance and contribution to ongoing scientific discussions and evidence development.[1]

Award Suitability

Assessment for the Innovative Research Award may consider factors including publication productivity, citation influence, research quality, and contribution to scientific advancement. Werner Mohl’s documented scholarly record demonstrates characteristics commonly associated with academic recognition. His bibliometric performance, institutional affiliation, and continued contribution to research activities collectively support consideration for distinction within the Global Diseases Research Awards framework.[1]

Conclusion

Werner Mohl’s academic profile reflects sustained scholarly productivity, measurable citation impact, and continued participation in biomedical and epidemiological research. Available indicators suggest a well-established research presence supported by peer-reviewed publications and scientific engagement. Based on the documented evidence, his professional achievements align with criteria frequently considered in international research award evaluations and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Werner Mohl, Author ID 21641111500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21641111500
  2. Global Diseases Research Awards. (n.d.). Award information and recognition framework.
    https://globaldiseases.org/
  3. Mohl, W., Spitzer, E., Mader, R. M., Wagh, V., Nguemo, F., Milasinovic, D., Jusić, A., Khazen, C., Szodorai, E., Birkenberg, B., Lubec, G., Hescheler, J., & Serruys, P. W. (2018). Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Failure, 5(5), 878–886.
    https://doi.org/10.1002/ehf2.12354
  4. Wagh, V., Nguemo, F., Kiseleva, Z., Mader, R. M., Hescheler, J., & Mohl, W. (2023). Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10-year survival. ESC Heart Failure, 10(6), 3921–3932. https://doi.org/10.1002/ehf2.14516
  5. Mohl, W., Kiseleva, Z., Jusić, A., Bruckner, M., & Mader, R. M. (2023). Signs and signals limiting myocardial damage using PICSO: A scoping review decoding paradigm shifts toward a new encounter. Frontiers in Cardiovascular Medicine, 10, 1030842. https://doi.org/10.3389/fcvm.2023.1030842

Ting Cheng | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Dr. Ting Cheng | Epidemiology | Research Excellence Award

Shanxi Medical University | China

Dr. Cheng Ting is a medical doctor and researcher affiliated with Shanxi Medical University, recognized for her contributions to autoimmune disease research, metabolic disorders, and chronic disease management. Her academic and clinical expertise spans rheumatology, endocrinology, osteoporosis, thyroid disorders, diabetes, and systemic autoimmune diseases. Dr. Cheng has actively contributed to translational medicine through clinical research projects and scientific publications focused on improving diagnosis, treatment, and patient outcomes. She has led provincial and hospital-level research projects and collaborated with national and international scientific communities. Her research achievements include SCI-indexed publications, academic book contributions, and patented medical innovations. Dr. Cheng has also gained international recognition through invited keynote lectures at major conferences, including EULAR and APLAR. Through her dedication to medical advancement, innovation, and patient-centered research, she continues to strengthen biomedical research and healthcare development both nationally and internationally.

Professional Profile

 

Education

Dr. Cheng Ting completed her medical education in China and earned her M.D. qualification with specialized training in internal medicine, autoimmune diseases, endocrinology, and chronic disease management. Her academic background provided extensive knowledge in clinical medicine, biomedical sciences, diagnostic methodologies, and evidence-based healthcare practices. During her advanced medical training, she developed strong expertise in rheumatology, osteoporosis research, metabolic diseases, and immune-related disorders. Her educational journey emphasized both theoretical medical sciences and practical clinical applications, enabling her to integrate patient care with scientific investigation. She further enhanced her academic profile through continuous participation in scientific conferences, professional workshops, and interdisciplinary medical collaborations. Her educational development also includes contributions to academic literature and participation in medical publishing activities. Through continuous learning and professional development, Dr. Cheng has established a strong academic foundation that supports her ongoing research in autoimmune diseases, metabolic health, chronic disease prevention, and translational clinical medicine.

Professional Experience

Dr. Cheng Ting has extensive professional experience in clinical medicine, biomedical research, and chronic disease management. She currently serves at Shanxi Medical University, where she combines patient care with advanced scientific research. Her clinical expertise includes the diagnosis and management of autoimmune diseases, osteoporosis, thyroid disorders, diabetes, and metabolic syndromes. Throughout her career, she has led two provincial and hospital-level research projects aimed at improving treatment strategies and healthcare outcomes. She has authored and co-authored several SCI-indexed research papers and contributed to multiple academic books related to medical sciences. Dr. Cheng also holds numerous national patents, reflecting her commitment to innovation and translational medicine. In addition to research and clinical responsibilities, she has been invited to present keynote speeches at internationally recognized conferences, including EULAR and APLAR. Her professional career demonstrates leadership, scientific excellence, and dedication to advancing global healthcare and medical research.

Research Interest 

Dr. Cheng Ting focuses her research on autoimmune diseases, metabolic disorders, rheumatology, endocrinology, and chronic disease prevention. Her studies investigate the mechanisms, diagnosis, and treatment strategies for conditions such as systemic sclerosis, osteoporosis, thyroid diseases, diabetes, and immune-mediated inflammatory disorders. She is particularly interested in translational medicine approaches that connect laboratory discoveries with clinical applications to improve patient outcomes. Her recent scientific contributions include research on viral infections and autoimmune diseases, as well as the clinical implications of nutritional interventions such as low-carbohydrate diets in autoimmune conditions. Dr. Cheng also emphasizes chronic disease management and preventive healthcare strategies aimed at reducing disease burden and improving long-term quality of life. Through multidisciplinary collaborations and evidence-based research methodologies, she continues to contribute to advancing biomedical science and precision medicine. Her research supports the development of innovative therapeutic approaches and improved healthcare systems for patients with autoimmune and metabolic disorders.

Awards and Honors

Dr. Cheng Ting has received several recognitions for her outstanding contributions to medical research, innovation, and healthcare advancement. One of her most notable achievements is receiving the Second Prize of the Shanxi Provincial Scientific and Technological Progress Award, which honors significant scientific contributions with practical healthcare impact. Her innovative work is further reflected in her ownership of 20 national patents related to medical technologies and healthcare solutions. Dr. Cheng has also earned professional recognition through invitations to deliver keynote speeches at major international and regional scientific conferences, including the European League Against Rheumatism (EULAR) and the Asia Pacific League of Associations for Rheumatology (APLAR). Her academic accomplishments include publishing multiple SCI-indexed papers and contributing to five academic books in the field of medicine and chronic disease management. These honors demonstrate her commitment to scientific innovation, translational medicine, clinical excellence, and international collaboration in biomedical and autoimmune disease research.

Conclusion

Dr. Cheng Ting  is a dedicated clinician, researcher, and innovator whose work significantly contributes to autoimmune disease research, metabolic medicine, and chronic disease management. With strong academic training, clinical expertise, research leadership, and international scientific engagement, she has established herself as an emerging contributor to biomedical and translational medicine. Her achievements include SCI-indexed publications, national patents, prestigious research awards, and keynote presentations at internationally recognized conferences. Dr. Cheng’s commitment to improving healthcare through scientific innovation and evidence-based medicine highlights her growing influence in global medical research. Her continued focus on interdisciplinary collaboration, translational medicine, and patient-centered healthcare positions her for further academic and professional excellence in the international biomedical research community.

Publications Top Noted

  • The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation
    Authors: Ming-Fu Lu
    Citation: Autoimmunity Reviews | DOI: 10.1016/j.autrev.2026.104071
  •  Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Authors: Ting Cheng
    Year: 2025
    Citation: Scientific Reports | DOI: Not provided

Daniel Lopez-Hernandez | Public Health | Research Excellence Award

Published on by Global Diseases Research

Dr. Daniel Lopez-Hernandez | Public Health | Research Excellence Award

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Mexico

Dr. Daniel López-Hernández is a researcher affiliated with the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico, with expertise rooted in applied medical and health sciences that support evidence-based public health and clinical practice. He has authored 16 peer-reviewed publications, which together have received 361 citations, reflecting the relevance and visibility of his work within the scientific community. With an h-index of 7, his research demonstrates consistent scholarly impact and influence. Dr. López-Hernández has collaborated with over 40 co-authors, highlighting strong interdisciplinary and international research engagement. His contributions address real-world health challenges, strengthening healthcare delivery systems and informing policy and clinical decision-making. Through sustained research productivity and collaboration, his work contributes to improving health outcomes and advancing medical knowledge with tangible societal benefit.

Citation Metrics (Scopus Preview)

361
270
180
`16
0

Citations

361

Documents

16

h-index

7

Citations

Documents

h-index

Note: h-index details are disabled in Scopus Preview mode.

View Scopus Profile   View Google Scholar Profile
Top 5 Featured Publications